广东岭南制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
49
NMPA:49
Drug Approvals
Compound Bismuth Aluminate Tablets
- Product Name
- 复方铝酸铋片
- Approval Number
- 国药准字H44024030
- Approval Date
- May 14, 2024
NMPA
Methotrexate for Injection
- Product Name
- 注射用甲氨蝶呤
- Approval Number
- 国药准字H20074246
- Approval Date
- May 14, 2024
NMPA
Calcium Folinate for Injection
- Product Name
- 福能
- Approval Number
- 国药准字H20057260
- Approval Date
- May 14, 2024
NMPA
Methotrexate for Injection
- Product Name
- 注射用甲氨蝶呤
- Approval Number
- 国药准字H20074222
- Approval Date
- May 14, 2024
NMPA
Berberine Hydrochloride Tablets
- Product Name
- 盐酸小檗碱片
- Approval Number
- 国药准字H44020105
- Approval Date
- May 14, 2024
NMPA
Methotrexate for Injection
- Product Name
- 注射用甲氨蝶呤
- Approval Number
- 国药准字H20054692
- Approval Date
- May 14, 2024
NMPA
Dacarbazine for Injection
- Product Name
- 注射用达卡巴嗪
- Approval Number
- 国药准字H20055753
- Approval Date
- May 14, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found